Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Deuterated Arachidonic Acid CYP450 Metabolite LC-MS Mixture

  • Zoom
    Deuterated Arachidonic Acid CYP450 Metabolite LC-MS Mixture
  • Deuterated Arachidonic Acid CYP450 Metabolite LC-MS Mixture
Cat No: 20667
Biochemicals - Isotopically Labeled Standards
Cayman

The deuterated arachidonic acid CYP450 metabolite LC-MS mixture contains deuterated versions of HETE and EET metabolites produced by the cytochrome P450 pathway of arachidonic acid metabolism. The mixture is supplied in an amber ampule in which the he...

More
: 1 ea

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Correlated keywords:
  • EET HETE CYP450 CYP-450 vasoconstriction hypertension LC-MS LC/MS LCMS deuterated deuterium isotope
Product Overview:
The deuterated arachidonic acid CYP450 metabolite LC-MS mixture contains deuterated versions of HETE and EET metabolites produced by the cytochrome P450 pathway of arachidonic acid metabolism. The mixture is supplied in an amber ampule in which the headspace has been purged with argon to prevent lipid oxidation. This product has been designed for direct use in LC-MS applications. This mixture is ideally suited for use as an internal standard in mass spectrometry applications. After opening, we recommend that the mixture be transferred immediately to a 1 ml glass screw cap vial, to prevent solvent evaporation, and stored at -20°C. The mixture should be discarded after multiple freeze/thaw cycles.This mixture contains deuterated forms of 20-HETE (Item No. 90030), (±)11(12)-EET (Item No. 50511), and (±)14(15)-EET (Item No. 50651), each of which have been shown to be involved in either vasoconstriction or hypertension.
Size 1 ea
Shipping dry ice
Formulation A solution in ethanol (1 µg/ml each compound)
Custom Code 3822.19
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : Deuterated Arachidonic Acid CYP450 Metabolite LC-MS Mixture There are 6 products.

Search